Synbiotic reduced the hepatic inflammation and apoptosis examined through the levels of PNPLA3, SREBP-1c, IL-6, TGF-β, Bcl-2, and caspase-3 in NASH models. Here, BCL2 is linked to metabolic dysfunction-associated steatohepatitis.